JP2025501239A5 - - Google Patents
Info
- Publication number
- JP2025501239A5 JP2025501239A5 JP2024539527A JP2024539527A JP2025501239A5 JP 2025501239 A5 JP2025501239 A5 JP 2025501239A5 JP 2024539527 A JP2024539527 A JP 2024539527A JP 2024539527 A JP2024539527 A JP 2024539527A JP 2025501239 A5 JP2025501239 A5 JP 2025501239A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antagonist
- subject
- age
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163295113P | 2021-12-30 | 2021-12-30 | |
| US63/295,113 | 2021-12-30 | ||
| PCT/US2022/082535 WO2023130010A1 (en) | 2021-12-30 | 2022-12-29 | Methods for attenuating atopic march by administering an il-4/il-13 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501239A JP2025501239A (ja) | 2025-01-17 |
| JP2025501239A5 true JP2025501239A5 (https=) | 2026-01-09 |
Family
ID=85199428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539527A Pending JP2025501239A (ja) | 2021-12-30 | 2022-12-29 | Ｉｌ－４／ｉｌ－１３アンタゴニストを投与することによってアトピーマーチを減弱する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230220089A1 (https=) |
| EP (1) | EP4457245A1 (https=) |
| JP (1) | JP2025501239A (https=) |
| KR (1) | KR20240135618A (https=) |
| CN (1) | CN118355034A (https=) |
| AU (1) | AU2022425608A1 (https=) |
| CA (1) | CA3241374A1 (https=) |
| IL (1) | IL313897A (https=) |
| MX (1) | MX2024006053A (https=) |
| WO (1) | WO2023130010A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| WO2021026205A1 (en) | 2019-08-05 | 2021-02-11 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2990420T3 (en) | 2000-05-26 | 2017-04-03 | Immunex Corp | USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| BRPI0416603A (pt) | 2003-11-07 | 2007-01-30 | Immunex Corp | anticorpo que se liga ao receptor interleucina-4 (il-4) humano |
| PL3718564T3 (pl) | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
| PE20060560A1 (es) | 2004-08-03 | 2006-06-27 | Novartis Ag | Anticuerpos de interleucina-4 humana |
| WO2006124451A2 (en) | 2005-05-11 | 2006-11-23 | Centocor, Inc. | Anti-il-13 antibodies, compositions, methods and uses |
| WO2007045477A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Human antibodies against il-13 and therapeutic uses |
| CA2646626A1 (en) | 2006-03-22 | 2007-09-27 | Apogenix Gmbh | Antibody specific for human il-4 for the treatment of cancer |
| JP2010502224A (ja) | 2006-09-08 | 2010-01-28 | アボット・ラボラトリーズ | インターロイキン１３結合タンパク質 |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| US20090148905A1 (en) | 2007-11-30 | 2009-06-11 | Claire Ashman | Antigen-binding constructs |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| GB0904214D0 (en) | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| WO2012049278A1 (en) | 2010-10-15 | 2012-04-19 | Medimmune Limited | Therapies for improving pulmonary function |
| PT3889181T (pt) * | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| JP2016522168A (ja) | 2013-04-05 | 2016-07-28 | ジェネンテック， インコーポレイテッド | 抗ｉｌ−４抗体及び二重特異性抗体及びその使用 |
| EP2823841A1 (en) | 2013-07-09 | 2015-01-14 | Sanofi-Aventis Deutschland GmbH | Autoinjector |
| TW201709941A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器（二） |
| TW201711713A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（五） |
| TW201707741A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 針頭護罩之抓握器、蓋子、自動注射器及製造抓握器之方法 |
| TW201711716A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 護罩鎖 |
| TW201707738A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 注射器支架及自動注射器（二） |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN111686247B (zh) | 2019-03-13 | 2022-07-29 | 苏州康乃德生物医药有限公司 | 包含人白介素-4受体α的抗体的液体组合物 |
| CN111592597B (zh) | 2019-05-29 | 2022-04-26 | 山东博安生物技术股份有限公司 | 白介素4受体(il-4r)结合蛋白及其用途 |
| MX2022011730A (es) * | 2020-03-27 | 2022-10-13 | Regeneron Pharma | Metodos para el tratamiento de dermatitis atopica mediante la administracion de un antagonista de il-4r. |
| CN113549151A (zh) | 2020-04-24 | 2021-10-26 | 苏州康乃德生物医药有限公司 | 与人IL-4Rα中特定表位结合的抗体及其应用 |
| US20230374144A1 (en) | 2020-09-10 | 2023-11-23 | Staidson (Beijing) Biopharmaceutical Co., Ltd. | Antibodies specifically recognizing interleukin-4 receptor alpha and uses thereof |
| KR20230123981A (ko) | 2020-12-23 | 2023-08-24 | 누맙 세러퓨틱스 아게 | Il-4r에 결합하는 항체 가변 도메인 |
| EP4019547A1 (en) | 2020-12-23 | 2022-06-29 | Numab Therapeutics AG | Multispecific antibodies having specificity for il-4r and il-31 |
-
2022
- 2022-12-29 US US18/147,983 patent/US20230220089A1/en active Pending
- 2022-12-29 CA CA3241374A patent/CA3241374A1/en active Pending
- 2022-12-29 AU AU2022425608A patent/AU2022425608A1/en active Pending
- 2022-12-29 KR KR1020247025561A patent/KR20240135618A/ko active Pending
- 2022-12-29 JP JP2024539527A patent/JP2025501239A/ja active Pending
- 2022-12-29 IL IL313897A patent/IL313897A/en unknown
- 2022-12-29 MX MX2024006053A patent/MX2024006053A/es unknown
- 2022-12-29 WO PCT/US2022/082535 patent/WO2023130010A1/en not_active Ceased
- 2022-12-29 EP EP22854747.7A patent/EP4457245A1/en active Pending
- 2022-12-29 CN CN202280080525.3A patent/CN118355034A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543612A5 (https=) | ||
| JP6306588B2 (ja) | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 | |
| CN105517570B (zh) | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 | |
| JP2025172841A5 (https=) | ||
| JP2021523188A5 (https=) | ||
| JP2023520676A5 (https=) | ||
| JP2024502471A5 (https=) | ||
| JP2020100653A (ja) | ベンラリツマブによる喘息症状の改善方法 | |
| TW202106334A (zh) | 藉由投予ｉｌ－３３拮抗劑治療或預防哮喘之方法 | |
| JP2025501239A5 (https=) | ||
| JP2024532263A5 (https=) | ||
| CN115697378A (zh) | 用cgrp抑制剂治疗肺部损伤的方法 | |
| JP2023531968A5 (https=) | ||
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| RU2024121393A (ru) | Способы ослабления атопического марша посредством введения антагониста il-4/il-13 | |
| JP7216157B2 (ja) | Ｉｌ－４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 | |
| RU2024107446A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2022105374A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2020140639A (ru) | Способы лечения атопического дерматита посредством введения ингибитора ил-4r | |
| HK40076109B (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| WO2025214333A1 (zh) | 抗tslp抗体治疗与tslp相关的炎症疾病的方法 | |
| HK40106058A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| WO2024077113A1 (en) | Methods of treating fatigue in ulcerative colitis | |
| RU2025102633A (ru) | Способы лечения педиатрического эозинофильного эзофагита путем введения антагониста il-4r | |
| RU2024129648A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r |